GlassScriptPhysician profile
Peter S Lund
NPI 1407881899
$1,718.36
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $88.58 · 2021: $179 · 2022: $292 · 2023: $414 · 2024: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $667.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $916.13 | 2019-2024 | Myrbetriq, Veozah |
| Progenics Pharmaceuticals, INC. | $234.08 | 2023-2024 | Pylarify |
| Blue Earth Diagnostics | $76.59 | 2019-2022 | |
| Boston Scientific Corporation | $64.42 | 2019-2023 | Ams 700 Cxr Rte Kit |
| Urovant Sciences INC | $57.90 | 2022 | |
| Procept Biorobotics Corporation | $47.89 | 2024 | Aquabeam System |
| Myovant Sciences INC. | $47.86 | 2021 | |
| Abbvie INC. | $45.38 | 2023-2024 | |
| Tolmar Pharmaceuticals, INC. | $37.55 | 2021-2022 | |
| Janssen Biotech, INC. | $31.14 | 2019 | |
| Sumitomo Pharma America, INC. | $28.83 | 2023 | Orgovyx |
| Axonics, INC. | $23.74 | 2021 | |
| Myriad Genetic Laboratories, INC. | $19.29 | 2023 | Prolaris |
| Neotract INC. | $16.08 | 2020 | |
| Endo Pharmaceuticals INC. | $15.37 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avadel Specialty Pharmaceuticals, LLC | $15.37 | 2019 | |
| Medtronic, INC. | $14.56 | 2023 | Interstim |
| 180 Medical, INC. | $13.34 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Lund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.